Cambrian BioPharma Sells Sensei Biotherapeutics Stock in Recent Transaction
Cambrian BioPharma Inc., a significant shareholder, recently executed the sale of a portion of its stake in Sensei Biotherapeutics, Inc. This transaction occurred as Sensei's stock has seen substantial gains over the past year. Despite the divestiture, the underlying clinical progress and analyst coverage for Sensei remain key focal points.